A detailed history of Williams & Novak, LLC transactions in Amgen Inc stock. As of the latest transaction made, Williams & Novak, LLC holds 1,304 shares of AMGN stock, worth $417,488. This represents 0.39% of its overall portfolio holdings.

Number of Shares
1,304
Previous 2,121 38.52%
Holding current value
$417,488
Previous $663 Million 36.61%
% of portfolio
0.39%
Previous 0.62%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$309.38 - $337.38 $252,763 - $275,639
-817 Reduced 38.52%
1,304 $420 Million
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $361,018 - $438,731
1,374 Added 183.94%
2,121 $663 Million
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $191,007 - $215,479
747 New
747 $215 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Williams & Novak, LLC Portfolio

Follow Williams & Novak, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Williams & Novak, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Williams & Novak, LLC with notifications on news.